Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.

Fucosylation is an important oligosaccharide modification associated with cancer and inflammation. We investigated whether urinary fucosylated PSA (Fuc-PSA) levels could be used for the detection of high Gleason score prostate cancer. Urine samples were collected from men with abnormal digital rectal examination findings or elevated serum PSA levels, before prostate biopsy. Lectin-antibody ELISA was used to quantify the Lewis-type or core-type fucosylated PSA (PSA-AAL) and core-type fucosylated PSA (PSA-PhoSL) in the urine samples. Both types of urinary Fuc-PSA were significantly decreased in the men with prostate cancer compared with the men whose biopsies were negative for cancer (P = 0.026 and P < 0.001, respectively). Both were also significantly associated with the Gleason scores of the biopsy specimens (P = 0.001 and P < 0.001, respectively). Multivariate analysis showed that PSA density, urinary PSA-AAL, and urinary PSA-PhoSL were independent predictors of high Gleason score prostate cancer. The area under the receiver-operator characteristic curve (AUC) value for the prediction of cancers of Gleason score ≥ 7 was 0.69 for urinary PSA-AAL and 0.72 for urinary PSA-PhoSL. In contrast, the AUC value was 0.59 for serum PSA, 0.63 for PSA density, and 0.58 for urinary PSA. In conclusion, a decreased urinary Fuc-PSA level is a potential marker for the detection of high Gleason score prostate cancer.

Oncotarget. 2016 Aug 01 [Epub ahead of print]

Kazutoshi Fujita, Takuji Hayashi, Kyosuke Matsuzaki, Wataru Nakata, Mika Masuda, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Mutsumi Tsuchiya, Yuka Kobayashi, Satoshi Nojima, Motohide Uemura, Eiichi Morii, Eiji Miyoshi, Norio Nonomura

Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., J-Oil Mills, Inc., Yokohama, Japan., Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan., Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine, Suita, Japan., Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe